BCL2L13-CECR2 Fusion FISH Probe
The BCL2L13-CECR2 Fusion FISH Probe is used to confirm a fusion of the BCL2L13 and CECR2 genes. The fusion of the BCL2L13 and CECR2 genes has been associated with Lung Squamous Cell Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| BCL2L13-CECR2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| BCL2L13-CECR2-20-RERE | 20 (40 μL) | 200 μL |
|
|
| BCL2L13-CECR2-20-REOR | 20 (40 μL) | 200 μL |
|
|
| BCL2L13-CECR2-20-REGO | 20 (40 μL) | 200 μL |
|
|
| BCL2L13-CECR2-20-REGR | 20 (40 μL) | 200 μL |
|
|
| BCL2L13-CECR2-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| BCL2L13-CECR2-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| BCL2L13-CECR2-20-OROR | 20 (40 μL) | 200 μL |
|
|
| BCL2L13-CECR2-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| BCL2L13-CECR2-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| BCL2L13-CECR2-20-GORE | 20 (40 μL) | 200 μL |
|
|
| BCL2L13-CECR2-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| BCL2L13-CECR2-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| BCL2L13-CECR2-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| BCL2L13-CECR2-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| BCL2L13-CECR2-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| BCL2L13-CECR2-20-GROR | 20 (40 μL) | 200 μL |
|
|
| BCL2L13-CECR2-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| BCL2L13-CECR2-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| BCL2L13-CECR2-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| BCL2L13-CECR2-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| BCL2L13-CECR2-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| BCL2L13-CECR2-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| BCL2L13-CECR2-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| BCL2L13-CECR2-20-AQAQ | 20 (40 μL) | 200 μL |
|
BCL2L13 Gene Summary
This gene encodes a mitochondrially-localized protein with conserved B-cell lymphoma 2 homology motifs. Overexpression of the encoded protein results in apoptosis. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Jul 2012]
Gene Name: BCL2 Like 13
Chromosome: CHR22: 18121484 -18211989
Locus: 22q11.21
CECR2 Gene Summary
This gene encodes a bromodomain-containing protein that is involved in chromatin remodeling, and may additionally play a role in DNA damage response. The encoded protein functions as part of an ATP-dependent complex that is involved in neurulation. This gene is a candidate gene for Cat Eye Syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]
Gene Name: CECR2, Histone Acetyl-lysine Reader
Chromosome: CHR22: 17956627 -18033845
Locus: 22q11.1-q11.21
Gene Diseases
The BCL2L13 CECR2 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Lung Squamous Cell Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|